26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse (Q40634818)
Jump to navigation
Jump to search
scientific article published on October 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse |
scientific article published on October 1994 |
Statements
1 reference
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse (English)
1 reference
B J Maron
1 reference
J M Isner
1 reference
W J McKenna
1 reference
1 October 1994
1 reference
1 reference
Identifiers
1 reference